HOVE vs NSIS-B: Side-by-Side Comparison
Compare Hove AS (HOVE) and Novonesis (Novozymes) A/S (NSIS-B) side by side: market cap DKK 144.62M vs DKK 191.95B, P/E 0.5 vs 43.1. Financials, growth and model signals on Bullrun.
| Metric | HOVE | NSIS-B |
|---|---|---|
| Company | Hove AS | Novonesis (Novozymes) A/S |
| Country / Exchange | Denmark · CO | Denmark · CO |
| Sector | Basic Materials | Basic Materials |
| Industry | Specialty Chemicals | Specialty Chemicals |
| Market cap | DKK 144.62M | DKK 191.95B |
| P/E ratio | 0.5 | 43.1 |
| Dividend yield | 2.30% | 1.57% |
| Valuation model | — | 7.3% overvalued |
| Revenue (latest FY) | — | EUR 4.16B |
| Revenue growth YoY | — | +8.5% |
| Net income | — | EUR 583.60M |
| Gross margin | — | 53.9% |
| Diluted EPS | — | 1.25 |